111 results
Page 2 of 6
S-8
EX-99.1
hwk2e3unu5
4 Dec 23
Registration of securities for employees
5:16pm
S-8
EX-99.2
ox8sk5 r826y7qyk
4 Dec 23
Registration of securities for employees
5:16pm
6-K
EX-99.1
ilmo8x
3 Nov 23
Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023
8:26am
6-K
EX-99.1
yk6ovuuf7fw
20 Sep 23
Galapagos appoints Simon Sturge to its Board of Directors
6:00am
6-K
EX-99.2
reh3zkt
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.1
xoa42tts8ypsq
4 Aug 23
Galapagos announces first half-year 2023 financial results
4:05pm
6-K
EX-99.1
ss7ajer
13 Jun 23
Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its Board
7:53am
6-K
EX-99.1
y2mhxg
5 May 23
Galapagos announces first quarter 2023 financial results
4:05pm
6-K
EX-99.1
vzt5yyf
31 Mar 23
Current report (foreign)
6:05am
6-K
EX-99.1
dhsp k9dyhkq
23 Dec 22
Galapagos announces changes to Executive Committee
6:05am
6-K
EX-99.1
no71m mixpnv4
13 Dec 22
Galapagos and CellPoint presented encouraging initial data at ASH 2022 for GLPG5101, a CD19 CAR-T candidate manufactured at point-of-care
7:49am
S-8
EX-99.3
qj8zzyfs
12 Dec 22
Registration of securities for employees
4:08pm
S-8
EX-99.1
cr51sj itw73hhl
12 Dec 22
Registration of securities for employees
4:08pm
S-8
EX-99.2
tcu2rrppd
12 Dec 22
Registration of securities for employees
4:08pm
6-K
EX-99.1
1cz6jwvkbur7k5e
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.2
tspc5
7 Nov 22
Galapagos announces strategy to accelerate innovation and reports strong third quarter 2022 results
6:08am
6-K
EX-99.1
te7ouo9bztf91j55
4 Nov 22
Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022
4:57pm
6-K
EX-99.1
7yutp8u847 i8058
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.2
3e5v4yplwkvz6 iq0pjj
8 Aug 22
First key steps in pipeline rebuild and strong commercial progress in H1 2022
4:59pm
6-K
EX-99.1
v1wtmjr5
23 Jun 22
Galapagos to acquire CellPoint and AboundBio to accelerate access to next-generation cell therapies
11:21am